A federal appeals court on Wednesday dismissed two patent challenges from Moderna over key components involved in making its COVID-19 vaccine.
A federal appeals court on Wednesday dismissed two patent challenges from Moderna over key components involved in making its COVID-19 vaccine.
Why it matters: The court's decision to side with Arbutus Biopharma means Arbutus could potentially sue Moderna for patent infringement and demand royalties from Moderna's COVID-19 vaccine, which is expected to generate up to $18 billion of revenue this year.
StreetLoc is one of America’s fastest-growing Social Media companies. We do not employ woke kids in California to “police” your thoughts and put you in “jail”.
StreetLoc is designed for Family, Friends, Events, Groups, Businesses and People. JOIN TODAY
StreetLoc is designed for Family, Friends, Events, Groups, Businesses and People. JOIN TODAY